3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
12
Carcinoma, Medullary
9
Lung Neoplasms
8
Thyroid Neoplasms
7
Neoplasms
5
Neoplasm Metastasis
5
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Carcinoma, Renal Cell
3
Breast Neoplasms
3
Stomach Neoplasms
2
Pleural Effusion
2
Kidney Neoplasms
2
Gliosarcoma
2
Glioblastoma
2
Familial medullary thyroid carcinoma
2
Fallopian Tube Neoplasms
2
Urinary Bladder Neoplasms
1
Thyroid cancer, medullary
1
Thyroid Diseases
1
Thyroid Cancer, Papillary
1
Small Cell Lung Carcinoma
1
Recurrence
1
Rectal Neoplasms
1
Precancerous Conditions
1
Peritoneal Neoplasms
1
Oligodendroglioma
1
Multiple Endocrine Neoplasia Type 2b
1
Multiple Endocrine Neoplasia Type 2a
1
Interventions
Carboplatin
12
Bevacizumab
10
Radiotherapy
9
Paclitaxel
9
Erlotinib Hydrochloride
9
Pemetrexed
7
Docetaxel
5
Taxes
4
Cisplatin
4
pegfilgrastim
3
Gemcitabine
3
Cetuximab
3
Radiotherapy, Conformal
2
Filgrastim
2
veliparib
1
romidepsin
1
pegylated granulocyte colony-stimulating factor
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
Watchful Waiting
1
Vinorelbine
1
Topotecan
1
Thalidomide
1
Temozolomide
1
Surgical Procedures, Operative
1
Sorafenib
1
Selenomethionine
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Radiation
1
Pneumonectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma, Bronchiolo-Alveolar
×
vandetanib
×
Clear all
No trials found.